Scope Fluidics S.A. (WSE:SCP)
137.00
-0.60 (-0.44%)
May 6, 2026, 5:00 PM CET
Scope Fluidics Market Cap
Scope Fluidics has a market cap or net worth of 434.05 million as of May 6, 2026. Its market cap has decreased by -13.37% in one year.
Market Cap
434.05M
Enterprise Value
325.77M
Revenue
100.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
137.00
Market Cap Chart
Since August 16, 2017, Scope Fluidics's market cap has increased from 41.31M to 434.05M, an increase of 950.62%. That is a compound annual growth rate of 30.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 435.95M | 1.03% |
| Dec 30, 2025 | 431.52M | -3.47% |
| Dec 30, 2024 | 447.05M | -16.33% |
| Dec 29, 2023 | 534.28M | -5.54% |
| Dec 30, 2022 | 565.63M | 54.38% |
| Dec 30, 2021 | 366.40M | 1.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.13B |
| NEUCA | 3.20B |
| Synektik Spólka Akcyjna | 2.45B |
| Celon Pharma | 1.14B |
| Selvita | 642.44M |
| Ryvu Therapeutics | 554.88M |
| Centrum Medyczne ENEL-MED | 537.33M |
| Captor Therapeutics Spolka Akcyjna | 500.65M |